Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Smoking Cessation in Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation in Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00963482).
- Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Smoking Cessation Intervention in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Intervention in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03024606).
- Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00332644).
- SMS TurkeyIndependent statistical analysis of SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SMV + SOF With/Without RBV for IFN-II Patients With CHC: Complete Statistical AnalysisIndependent statistical analysis of SMV + SOF With/Without RBV for IFN-II Patients With CHC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02214420).
- SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients): Complete Statistical AnalysisIndependent statistical analysis of SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SOCIALIndependent statistical analysis of Supporting Our Caregivers In ADRD Learning (SOCIAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06276023).
- Social Media Intervention for Cannabis Use in Emerging Adults: Complete Statistical AnalysisIndependent statistical analysis of Social Media Intervention for Cannabis Use in Emerging Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04187989).
- Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities: Complete Statistical AnalysisIndependent statistical analysis of Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SoCIWHIVIndependent statistical analysis of Smoking Cessation Intervention for Women Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898597).
- Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03752203).
- Sodium Nitroprusside in Early Course Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Sodium Nitroprusside in Early Course Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04986072).
- Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04824365).
- Sodium Risedronate Tablets – Special Drug Use Surveillance in Patients With Osseous Paget’s Disease (All-case Surveillance) -48-week Surveillance -: Complete Statistical AnalysisIndependent statistical analysis of Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -: primary endpoint results, effect estimate with confidence interval, sample-size…
- SOF/VEL ESRDIndependent statistical analysis of Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection: primary endpoint results,…
- Soft Tissue Mobilization Versus Therapeutic Ultrasound for Subjects With Neck and Arm Pain: Complete Statistical AnalysisIndependent statistical analysis of Soft Tissue Mobilization Versus Therapeutic Ultrasound for Subjects With Neck and Arm Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant: Complete Statistical AnalysisIndependent statistical analysis of Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SOLANAIndependent statistical analysis of A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation: primary endpoint…
- SOLARIndependent statistical analysis of Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SOLAR-1Independent statistical analysis of Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.: primary…
- SOLEOIndependent statistical analysis of A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SOLMYD-PDIndependent statistical analysis of Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SOLO3Independent statistical analysis of Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received…
- SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes: Complete Statistical AnalysisIndependent statistical analysis of SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Somatosensory Profiling in Radicular Pain Patients And it’s Correlation With Treatment Outcome: Complete Statistical AnalysisIndependent statistical analysis of Somatosensory Profiling in Radicular Pain Patients And it's Correlation With Treatment Outcome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SOMNOSIndependent statistical analysis of Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01503164).
- SONARIndependent statistical analysis of Sentinel Node Detection in Clinical Early Stage Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01734746).
- Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SONNETIndependent statistical analysis of Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02231762).
- Sonoelastography: Ultrasound Method to Measure Liver Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Sonoelastography: Ultrasound Method to Measure Liver Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747772).
- SONOMAIndependent statistical analysis of Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Sonothrombolysis in Patients With STEMI: Complete Statistical AnalysisIndependent statistical analysis of Sonothrombolysis in Patients With STEMI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03092089).
- SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization: Complete Statistical AnalysisIndependent statistical analysis of SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SONRISAIndependent statistical analysis of Study of Neural Responses Induced by Antidepressant Effects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02674529).
- SOPRAIndependent statistical analysis of Selinexor (KPT-330) in Older Patients With Relapsed AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02088541).
- SOPTIndependent statistical analysis of Sleep Optimization to Improve Glycemic Control in Adults With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01510756).
- Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00126568).
- Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00131911).